Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1953 4
1954 1
1956 3
1957 2
1958 5
1959 4
1960 17
1961 15
1962 24
1963 15
1964 31
1965 24
1966 35
1967 36
1968 46
1969 31
1970 33
1971 46
1972 34
1973 35
1974 67
1975 40
1976 51
1977 53
1978 49
1979 72
1980 83
1981 74
1982 106
1983 114
1984 120
1985 128
1986 119
1987 128
1988 173
1989 180
1990 214
1991 199
1992 226
1993 223
1994 259
1995 251
1996 273
1997 284
1998 274
1999 290
2000 314
2001 325
2002 279
2003 349
2004 338
2005 373
2006 341
2007 343
2008 379
2009 417
2010 425
2011 485
2012 516
2013 505
2014 525
2015 545
2016 524
2017 500
2018 540
2019 549
2020 619
2021 701
2022 549
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

13,793 results
Results by year
Filters applied: . Clear all
Page 1
A cross-population atlas of genetic associations for 220 human phenotypes.
Sakaue S, Kanai M, Tanigawa Y, Karjalainen J, Kurki M, Koshiba S, Narita A, Konuma T, Yamamoto K, Akiyama M, Ishigaki K, Suzuki A, Suzuki K, Obara W, Yamaji K, Takahashi K, Asai S, Takahashi Y, Suzuki T, Shinozaki N, Yamaguchi H, Minami S, Murayama S, Yoshimori K, Nagayama S, Obata D, Higashiyama M, Masumoto A, Koretsune Y; FinnGen, Ito K, Terao C, Yamauchi T, Komuro I, Kadowaki T, Tamiya G, Yamamoto M, Nakamura Y, Kubo M, Murakami Y, Yamamoto K, Kamatani Y, Palotie A, Rivas MA, Daly MJ, Matsuda K, Okada Y. Sakaue S, et al. Among authors: yamamoto k. Nat Genet. 2021 Oct;53(10):1415-1424. doi: 10.1038/s41588-021-00931-x. Epub 2021 Sep 30. Nat Genet. 2021. PMID: 34594039
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Watanabe H, Morimoto T, Natsuaki M, Yamamoto K, Obayashi Y, Ogita M, Suwa S, Isawa T, Domei T, Yamaji K, Tatsushima S, Watanabe H, Ohya M, Tokuyama H, Tada T, Sakamoto H, Mori H, Suzuki H, Nishikura T, Wakabayashi K, Hibi K, Abe M, Kawai K, Nakao K, Ando K, Tanabe K, Ikari Y, Morino Y, Kadota K, Furukawa Y, Nakagawa Y, Kimura T; STOPDAPT-2 ACS Investigators. Watanabe H, et al. Among authors: yamamoto k. JAMA Cardiol. 2022 Apr 1;7(4):407-417. doi: 10.1001/jamacardio.2021.5244. JAMA Cardiol. 2022. PMID: 35234821 Clinical Trial.
JCS/JHFS 2021 Guideline Focused Update on Diagnosis and Treatment of Acute and Chronic Heart Failure.
Tsutsui H, Ide T, Ito H, Kihara Y, Kinugawa K, Kinugawa S, Makaya M, Murohara T, Node K, Saito Y, Sakata Y, Shimizu W, Yamamoto K, Bando Y, Iwasaki YK, Kinugasa Y, Mizote I, Nakagawa H, Oishi S, Okada A, Tanaka A, Akasaka T, Ono M, Kimura T, Kosaka S, Kosuge M, Momomura SI. Tsutsui H, et al. Among authors: yamamoto k. J Card Fail. 2021 Dec;27(12):1404-1444. doi: 10.1016/j.cardfail.2021.04.023. Epub 2021 Sep 28. J Card Fail. 2021. PMID: 34600838 Review. No abstract available.
A histone modifier, ASXL1, interacts with NONO and is involved in paraspeckle formation in hematopoietic cells.
Yamamoto K, Goyama S, Asada S, Fujino T, Yonezawa T, Sato N, Takeda R, Tsuchiya A, Fukuyama T, Tanaka Y, Yokoyama A, Toya H, Kon A, Nannya Y, Onoguchi-Mizutani R, Nakagawa S, Hirose T, Ogawa S, Akimitsu N, Kitamura T. Yamamoto K, et al. Cell Rep. 2021 Aug 24;36(8):109576. doi: 10.1016/j.celrep.2021.109576. Cell Rep. 2021. PMID: 34433054 Free article.
Measurable Residual Disease Response and Prognosis in Treatment-Naïve Acute Myeloid Leukemia With Venetoclax and Azacitidine.
Pratz KW, Jonas BA, Pullarkat V, Recher C, Schuh AC, Thirman MJ, Garcia JS, DiNardo CD, Vorobyev V, Fracchiolla NS, Yeh SP, Jang JH, Ozcan M, Yamamoto K, Illes A, Zhou Y, Dail M, Chyla B, Potluri J, Döhner H. Pratz KW, et al. Among authors: yamamoto k. J Clin Oncol. 2022 Mar 10;40(8):855-865. doi: 10.1200/JCO.21.01546. Epub 2021 Dec 15. J Clin Oncol. 2022. PMID: 34910556 Clinical Trial.
Metagenome-wide association study revealed disease-specific landscape of the gut microbiome of systemic lupus erythematosus in Japanese.
Tomofuji Y, Maeda Y, Oguro-Igashira E, Kishikawa T, Yamamoto K, Sonehara K, Motooka D, Matsumoto Y, Matsuoka H, Yoshimura M, Yagita M, Nii T, Ohshima S, Nakamura S, Inohara H, Takeda K, Kumanogoh A, Okada Y. Tomofuji Y, et al. Among authors: yamamoto k. Ann Rheum Dis. 2021 Dec;80(12):1575-1583. doi: 10.1136/annrheumdis-2021-220687. Epub 2021 Aug 23. Ann Rheum Dis. 2021. PMID: 34426398 Free PMC article.
Secreted phospholipase A2 modifies extracellular vesicles and accelerates B cell lymphoma.
Kudo K, Miki Y, Carreras J, Nakayama S, Nakamoto Y, Ito M, Nagashima E, Yamamoto K, Higuchi H, Morita SY, Inoue A, Aoki J, Ando K, Nakamura N, Murakami M, Kotani A. Kudo K, et al. Among authors: yamamoto k. Cell Metab. 2022 Apr 5;34(4):615-633.e8. doi: 10.1016/j.cmet.2022.02.011. Epub 2022 Mar 15. Cell Metab. 2022. PMID: 35294862
Half-and-Half Toenails.
Yamamoto K, Otsuka F. Yamamoto K, et al. Mayo Clin Proc. 2022 Apr;97(4):652. doi: 10.1016/j.mayocp.2022.01.010. Mayo Clin Proc. 2022. PMID: 35379418 No abstract available.
Distinct transcriptome architectures underlying lupus establishment and exacerbation.
Nakano M, Ota M, Takeshima Y, Iwasaki Y, Hatano H, Nagafuchi Y, Itamiya T, Maeda J, Yoshida R, Yamada S, Nishiwaki A, Takahashi H, Takahashi H, Akutsu Y, Kusuda T, Suetsugu H, Liu L, Kim K, Yin X, Bang SY, Cui Y, Lee HS, Shoda H, Zhang X, Bae SC, Terao C, Yamamoto K, Okamura T, Ishigaki K, Fujio K. Nakano M, et al. Among authors: yamamoto k. Cell. 2022 Sep 1;185(18):3375-3389.e21. doi: 10.1016/j.cell.2022.07.021. Epub 2022 Aug 22. Cell. 2022. PMID: 35998627
Deep brain stimulation targets in epilepsy: Systematic review and meta-analysis of anterior and centromedian thalamic nuclei and hippocampus.
Vetkas A, Fomenko A, Germann J, Sarica C, Iorio-Morin C, Samuel N, Yamamoto K, Milano V, Cheyuo C, Zemmar A, Elias G, Boutet A, Loh A, Santyr B, Gwun D, Tasserie J, Kalia SK, Lozano AM. Vetkas A, et al. Among authors: yamamoto k. Epilepsia. 2022 Mar;63(3):513-524. doi: 10.1111/epi.17157. Epub 2022 Jan 3. Epilepsia. 2022. PMID: 34981509 Review.
13,793 results
You have reached the last available page of results. Please see the User Guide for more information.